Bloomage Reconciled Depreciation from 2010 to 2024

688363 Stock   57.50  3.32  5.46%   
Bloomage Biotechnology's Reconciled Depreciation is increasing over the years with slightly volatile fluctuation. Reconciled Depreciation is expected to dwindle to about 134 M. From 2010 to 2024 Bloomage Biotechnology Reconciled Depreciation quarterly data regression line had arithmetic mean of  85,843,522 and r-squared of  0.57. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2010-12-31
Previous Quarter
264.7 M
Current Value
134 M
Quarterly Volatility
71.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bloomage Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bloomage Biotechnology's main balance sheet or income statement drivers, such as Interest Expense of 11.3 M, Other Operating Expenses of 6.3 B or Net Income Applicable To Common Shares of 562.4 M, as well as many indicators such as . Bloomage financial statements analysis is a perfect complement when working with Bloomage Biotechnology Valuation or Volatility modules.
  
This module can also supplement various Bloomage Biotechnology Technical models . Check out the analysis of Bloomage Biotechnology Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Bloomage Stock

Bloomage Biotechnology financial ratios help investors to determine whether Bloomage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bloomage with respect to the benefits of owning Bloomage Biotechnology security.